Vimarsana
Biggest News Aggregation in the World

Page 2 - Nasdaq Dffn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Dffn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Dffn Today - Breaking & Trending Today

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Short Interest Update - Vimarsana News

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Short Interest Update

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Free Report) was the target of a large decline in short interest in the month of June. As of June 30th, there was short interest totalling 1,400 shares, a decline of 71.4% from the June 15th total of 4,900 shares. Based on an average daily trading volume, of 8,200 […]

Diffusion Pharmaceuticals (NASDAQ:DFFN) Now Covered by StockNews.com - Vimarsana News

Diffusion Pharmaceuticals (NASDAQ:DFFN) Now Covered by StockNews.com

StockNews.com started coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a report released on Sunday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of DFFN stock opened at $3.01 on Friday. The business has a 50 day moving average of $3.61 and a two-hundred day moving […]

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Short Interest Down 23.4% in June - Vimarsana News

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Short Interest Down 23.4% in June

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Free Report) saw a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 4,900 shares, a decline of 23.4% from the May 31st total of 6,400 shares. Based on an average trading volume of 8,000 shares, the days-to-cover ratio is […]

Source: wkrb13.com
Diffusion Pharmaceuticals (NASDAQ:DFFN) Earns Hold Rating from Analysts at StockNews.com - Vimarsana News

Diffusion Pharmaceuticals (NASDAQ:DFFN) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a report released on Thursday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance DFFN stock opened at $3.53 on Thursday. Diffusion Pharmaceuticals has a fifty-two week low of $3.42 and a fifty-two week high of $8.74. The […]

Source: wkrb13.com
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Sees Significant Drop in Short Interest - Vimarsana News

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Sees Significant Drop in Short Interest

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the recipient of a significant decrease in short interest during the month of May. As of May 31st, there was short interest totalling 6,400 shares, a decrease of 34.0% from the May 15th total of 9,700 shares. Approximately 0.3% of the company’s stock are sold short. Based […]